Showing results (101-110 of 233) with videos related to

Sort By:
Pageof 24
Nutrition and Cancer|February 6, 2016
Alleviating Effect of Active Hexose Correlated Compound (AHCC) on Chemotherapy-Related Adverse Events in Patients with Unresectable Pancreatic Ductal AdenocarcinomaHiroaki Yanagimoto, Sohei Satoi, Tomohisa Yamamoto, et al.
Pancreas|June 29, 2006
Less morbidity after pancreaticoduodenectomy of patients with pancreatic cancerSohei Satoi, Soichiro Takai, Yoichi Matsui, et al.
Oncology Reports|July 29, 2010
A phase II study of personalized peptide vaccination combined with gemcitabine for non-resectable pancreatic cancer patientsHiroaki Yanagimoto, Hisanori Shiomi, Sohei Satoi, et al.
The American Surgeon|January 10, 2014
Clinical impact of preoperative cholangitis after biliary drainage in patients who undergo pancreaticoduodenectomy on postoperative pancreatic fistulaHiroaki Yanagimoto, Sohei Satoi, Tomohisa Yamamoto, et al.
Oncology|July 19, 2017
Effect of Neoadjuvant Nab-Paclitaxel plus Gemcitabine Therapy on Overall Survival in Patients with Borderline Resectable Pancreatic Cancer: A Prospective Multicenter Phase II Trial (NAC-GA Trial)Ken-Ichi Okada, Toshio Shimokawa, Seiko Hirono, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|June 28, 2013
Less morbidity after introduction of a new departmental policy for patients who undergo open distal pancreatectomyRintaro Yui, Sohei Satoi, Hideyoshi Toyokawa, et al.
World Journal of Surgical Oncology|January 22, 2016
A clinical role of staging laparoscopy in patients with radiographically defined locally advanced pancreatic ductal adenocarcinomaSohei Satoi, Hiroaki Yanagimoto, Tomohisa Yamamoto, et al.
Trials|February 13, 2022
Efficacy of active hexose correlated compound on survival of patients with resectable/borderline resectable pancreatic cancer: a study protocol for a double-blind randomized phase II studyDaisuke Hashimoto, Sohei Satoi, Hideki Ishikawa, et al.
Internal Medicine (Tokyo, Japan)|November 3, 2015
Successful Multidisciplinary Therapy for Small Cell Carcinomas Arising from the Extrahepatic Bile DuctKoh Nakamaru, Tsukasa Ikeura, Hideaki Miyoshi, et al.
Annals of Surgical Oncology|October 21, 2024
Neoadjuvant Treatment with Changes in Chemotherapy Regimens According to Carbohydrate Antigen 19-9 Level for Resectable/Borderline Resectable Pancreatic Ductal AdenocarcinomaDaisuke Hashimoto, Sohei Satoi, So Yamaki, et al.
Pageof 24